Table 3.
Comparison of Qmax, PVR & IPSS Score
| Parameters (mean+SD) | Follow-up points | Tamsulosin | Silodosin | p value | 95% CI |
|---|---|---|---|---|---|
| (Group A) | (Group B) | ||||
| Qmax (ml/sec) | At successful TWOC | 11.3 + 1.9 | 10.8 + 1.7 | 0.081 | (-0.06, 1.06) |
| Two week after successful TWOC | 12.8 + 1.2 | 12.6 + 1.3 | 0.313 | (-0.19, 0.59) | |
| One month after successful TWOC | 14.1 + 1.7 | 13.9 + 1.6 | 0.445 | (-0.32, 0.72) | |
| PVR urine volume (ml) | At successful TWOC | 92.6 + 16.3 | 91.1 + 17.2 | 0.572 | (-3.73, 6.73) |
| Two week after successful TWOC | 85.6 + 17.3 | 86.3 + 16.2 | 0.792 | (-5.93, 4.53) | |
| One month after successful TWOC | 70.6 + 18.3 | 72.1 + 17.2 | 0.594 | (-7.05, 4.05) | |
| IPSS | At successful TWOC | 14.4 + 2.8 | 14.1 + 2.1 | 0.445 | (-0.47, 1.07) |
| Two week after successful TWOC | 13.3 + 2.1 | 13.7 + 1.7 | 0.187 | (-0.99, 0.20) | |
| One month after successful TWOC | 12.1 + 2.8 | 11.9 + 2.1 | 0.610 | (-0.57, 0.97) |